Biodeal Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 25.45 Cr
as on 31-08-2024
- Paid Up Capital ₹ 25.34 Cr
as on 31-08-2024
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 213.31 Cr
as on 31-08-2024
- Satisfied Charges ₹ 102.72 Cr
as on 31-08-2024
- Revenue 40.45%
(FY 2023)
- Profit 28.10%
(FY 2023)
- Ebitda -26.76%
(FY 2023)
- Net Worth 6.74%
(FY 2023)
- Total Assets 22.92%
(FY 2023)
About Biodeal Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.45 Cr and a paid-up capital of Rs 25.34 Cr.
The company currently has active open charges totaling ₹213.31 Cr. The company has closed loans amounting to ₹102.72 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Biodeal Pharmaceuticals Limited India are Prabhat Kumar as CFO and Sirat Arora as Company Secretary. Anurag Kumar, Dev Datt, Puja Kasera, and Three other members serve as directors at the Company.
- CIN/LLPIN
U00304HP2005PLC029451
- Company No.
029451
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Dec 2005
- Date of AGM
29 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- LocationNalagarh, Distt. Solan (Hp)., Himachal Pradesh
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biodeal Pharmaceuticals Limited offer?
Biodeal Pharmaceuticals Limited offers a wide range of products and services, including Anti Acne Drug, Tazret Forte, Hand Sanitizer & Disinfectant, Alcohol Based Hand Sanitizer, Company Law & Labour Law Consultants, Statutory Compliance Services, Pharma Ingredients & Raw Materials, Antipyretic and Analgesic API, Business Planning and Management, Business Consultant.
Who are the key members and board of directors at Biodeal Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anurag Kumar  | Managing Director | 01-Nov-2019 | Current |
| Prabhat Kumar | CFO | 01-Nov-2023 | Current |
| Sirat Arora | Company Secretary | 13-Feb-2023 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Puja Kasera | Director | 20-Jan-2023 | Current |
| Dev Datt | Director | 01-Apr-2021 | Current |
| Gurudutta Mishra | Nominee Director | 16-Jul-2024 | Current |
| Anchal Kumari | Director | 30-Nov-2022 | Current |
| Noopur Jha | Additional Director | 03-Jul-2024 | Current |
Financial Performance and Corporate Structure Insights of Biodeal Pharmaceuticals.
Biodeal Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.45% increase. The company also saw a substantial improvement in profitability, with a 28.1% increase in profit. The company's net worth moved up by a moderate rise of 6.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biodeal Pharmaceuticals?
In 2023, Biodeal Pharmaceuticals had a promoter holding of 99.88% and a public holding of 0.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Transaction Solutions International (India) Private LimitedActive 19 years 8 monthsGurudutta Mishra is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Feb 2024 | ₹160.00 Cr | Open |
Yes Bank Limited Creation Date: 21 Aug 2023 | ₹33.00 Cr | Open |
Standard Chartered Bank Creation Date: 24 Feb 2023 | ₹17.00 Cr | Open |
How Many Employees Work at Biodeal Pharmaceuticals?
Biodeal Pharmaceuticals has a workforce of 284 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biodeal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biodeal Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
